These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 271142)

  • 1. Tumor-associated humoral cytotoxicity in patients with acute myelogenous leukemia before and after chemotherapy.
    Fäldt R; Ankerst J
    Int J Cancer; 1977 Dec; 20(6):824-33. PubMed ID: 271142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of antibody-associated cellular cytotoxicity in patients with acute myelogenous leukemia before and after chemotherapy.
    Fäldt R; Ankerst J
    Int J Cancer; 1979 Jul; 24(1):17-26. PubMed ID: 289631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of antibody-dependent cellular cytotoxicity and mitogen-induced cellular cytotoxicity effector cell function in patients with acute myelogenous leukemia in remission.
    Zighelboim J
    Cancer Res; 1979 Sep; 39(9):3357-62. PubMed ID: 314332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possibly specific immune complexes in sera of patients with untreated acute myelogenous leukemia.
    Fäldt R; Ankerst J
    Int J Cancer; 1980 Sep; 26(3):309-14. PubMed ID: 6945292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody dependent cellular cytotoxicity and complement mediated cytotoxicity on leukemic cells mediated by anti K562 monoclonal antibodies.
    Tatake RJ; Maniar HS; Chiplunkar SV; Somasundaram R; Amin MK; Saikia T; Gangal SG
    J Clin Lab Immunol; 1990 Feb; 31(2):87-91. PubMed ID: 1966990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of heteroantisera to human acute leukemia-associated antigens.
    Baker MA; Ramachandar K; Taub RN
    J Clin Invest; 1974 Dec; 54(6):1273-8. PubMed ID: 4140196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of an antigen associated with acute leukemia.
    Mann DL; Rogentine GN; Halterman R; Leventhal B
    Science; 1971 Dec; 174(4014):1136-7. PubMed ID: 5289583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An acute-leukemia antigen: correlation with clinical status.
    Halterman RH; Leventhal BG; Mann DL
    N Engl J Med; 1972 Dec; 287(25):1272-4. PubMed ID: 4508573
    [No Abstract]   [Full Text] [Related]  

  • 9. Inability to demonstrate lytic antibodies to autologous leukaemia cells in the sera from remission patients with acute myelogenous leukaemia treated with active specific immunotherapy.
    Chapuis BJ; Powles R; Alexander P
    Clin Exp Immunol; 1978 May; 32(2):253-8. PubMed ID: 276431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity of antisera to a myelogenous leukemia cell line with the Philadelphia chromosome.
    Whitson ME; Lozzio CB; Lozzio BB; Wust CJ; Sonoda T; Avery B
    J Natl Cancer Inst; 1976 May; 56(5):903-7. PubMed ID: 1069137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous infusion of complement by an automated cell processor enhances cytotoxicity of monoclonal antibody sensitized leukemia cells.
    Howell AL; Fogg-Leach M; Davis BH; Ball ED
    Bone Marrow Transplant; 1989 May; 4(3):317-22. PubMed ID: 2659117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the ability of monoclonal antibodies to selectively mediate complement-dependent cytotoxicity of human myelogenous leukemia blast cells.
    Ball ED; Kadushin JM; Schacter B; Fanger MW
    J Immunol; 1982 Mar; 128(3):1476-81. PubMed ID: 6948897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytotoxic antibodies to leukemia cells in normal human sera].
    Dorè JF; Bertoglio J; Guibout C
    Ann Immunol (Paris); 1977; 128(1-2):155-7. PubMed ID: 265695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dynamics of the change in the immunoglobulin concentration in the serum of children with acute leukemia against a background of chemotherapy].
    Kisliak NS; Smirnov VV
    Vopr Okhr Materin Det; 1975 Oct; 20(10):36-9. PubMed ID: 1060242
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunologic studies in acute leukemia.
    Santos GW; Mullins GM; Bias WB; Anderson PN; Graziano KD; Klein DL; Burke PJ
    Natl Cancer Inst Monogr; 1973 Jun; 37():69-75. PubMed ID: 4268325
    [No Abstract]   [Full Text] [Related]  

  • 16. [Receptor for immunoglobulins and complement on circulating leukoblasts in acute myeloblastic leukemia].
    Vuvan H; Revol L; Revillard JP; Samrut C
    Nouv Presse Med; 1976 Oct; 5(32):2084-5. PubMed ID: 1068441
    [No Abstract]   [Full Text] [Related]  

  • 17. Cutaneous delayed hypersensitivity responses to tumor-associated and other antigens in acute leukemia.
    Char DH; Lepourhiet BG; Herberman RB
    Int J Cancer; 1973 Sep; 12(2):409-19. PubMed ID: 4524930
    [No Abstract]   [Full Text] [Related]  

  • 18. Applicability of antimyeloid monoclonal antibodies (L4F3, 1G10) to autologous bone marrow transplantation for patients with acute myelogenous leukemia.
    Takahashi M; Maruyama S; Moriyama Y; Shibata A
    Transplant Proc; 1992 Feb; 24(1):416-8. PubMed ID: 1539334
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunoglobulin on tumor cells and tumor-induced lymphocyte blastogenesis in human acute leukemia.
    Gutterman JU; Rossen RD; Butler WT; McCredie KB; Bodey GP; Freireich EJ; Hersh EM
    N Engl J Med; 1973 Jan; 288(4):169-75. PubMed ID: 4565852
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of the proteolytic enzyme brinase to produce autocytotoxicity in patients with acute leukemia and its possible role in immunotherapy.
    Thornes RD; Deasy PF; Carroll R; Reen DJ; MacDonnel JD
    Cancer Res; 1972 Feb; 32(2):280-4. PubMed ID: 4512605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.